$GILD Company News
Post# of 102254
Posted On: 11/20/2014 12:49:42 PM
$GILD Company News
Gilead Sciences shares slide 1.7%
9:35 a.m. Nov. 19, 2014
- Sue Chang
Are consumers getting gouged on health care?
12:58 p.m. Nov. 18, 2014
- Russ Britt
The double-edged sword of growth-stock speculation
2:29 p.m. Nov. 14, 2014
- The Trading Deck
10 S&P 500 companies with the fastest revenue growth
8:28 a.m. Nov. 11, 2014
- Philip van Doorn
Merck, Dendreon miss out on health-care rally
12:39 p.m. Nov. 10, 2014
- Russ Britt
Gilead Sciences rises 2% to top S&P 500 gainers
9:31 a.m. Nov. 10, 2014
- Sue Chang
Visa shares rise after hours on earnings beat
6:50 p.m. Oct. 29, 2014
- Sue Chang
Warren Buffett best wear his trunks as Fed preps to end (pause) the printing
8:34 a.m. Oct. 29, 2014
- Shawn Langlois
Facebook, Gilead shares fall after hours
6:14 p.m. Oct. 28, 2014
- Sue Chang
Updates, advisories and surprises
5:01 p.m. Oct. 28, 2014
- MarketWatch
Sales of Gilead's pricey hepatitis C drug slow
4:26 p.m. Oct. 28, 2014
- MarketWatch.com
Gilead Sciences' stock pulls back from record high close after earnings miss
4:14 p.m. Oct. 28, 2014
- Tomi Kilgore
Gilead's stock drops 3.6% in after-hours trade after Q3 results
4:09 p.m. Oct. 28, 2014
- Tomi Kilgore
Gilead revises 2014 product sales outlook to $22 bln-$23 bln from $21 bln-$23 bln
4:08 p.m. Oct. 28, 2014
- Tomi Kilgore
Gilead Q3 Sovaldi sales $2.8 bln vs. $3.48 bln in Q2
4:07 p.m. Oct. 28, 2014
- Tomi Kilgore
Gilead Q3 sales top FactSet consensus estimate of $5.99 bln
4:07 p.m. Oct. 28, 2014
- Tomi Kilgore
Gilead Q3 sales $6.04 bln vs. $2.78 bln a year ago
4:07 p.m. Oct. 28, 2014
- Tomi Kilgore
Gilead Q3 net EPS $1.67 vs. 47 cents a year ago
4:06 p.m. Oct. 28, 2014
- Tomi Kilgore
Gilead Sciences Q3 adj. EPS $1.84 vs. FactSet consensus $1.92
4:06 p.m. Oct. 28, 2014
- Tomi Kilgore
Two biotech leaders to watch
2:12 p.m. Oct. 28, 2014
- The Trading Deck
France gets larger discount on Sovaldi than its neighbors
45 min ago12:04 p.m. Nov. 20, 2014
- Seeking Alpha
Global drug tab will breach trillion dollar mark this year
7:41 a.m. Today7:41 a.m. Nov. 20, 2014
- Seeking Alpha
CNBC's Stock Pops & Drops From November 19
6:38 a.m. Today6:38 a.m. Nov. 20, 2014
- benzinga.com
Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog
5:57 p.m. Nov. 19, 2014
- Zacks.com
Why We're Huge Fans Of Gilead
4:33 p.m. Nov. 19, 2014
- Seeking Alpha
Gilead buys FDA voucher for $125M
3:59 p.m. Nov. 19, 2014
- Seeking Alpha
Gilead: Pipeline Now Includes Potential Renal Blockbuster
11:35 a.m. Nov. 19, 2014
- Seeking Alpha
Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog
11:23 a.m. Nov. 19, 2014
- Zacks.com
Update: Gilead's Harvoni Receives Marketing Authorization In Europe
11:17 a.m. Nov. 19, 2014
- Seeking Alpha
Stock Market News for November 19, 2014 - Market News
10:10 a.m. Nov. 19, 2014
- Zacks.com
Stock Market Today: Oil Slump Fuels S&P 500 to Fresh Record High
4:09 p.m. Nov. 18, 2014
- TheStreet.com
Gilead's Value Without Its Hep C Franchise
4:07 p.m. Nov. 18, 2014
- Seeking Alpha
Stock Market Today: S&P 500 Notches New High as Oil Prices Slip and Slide
2:23 p.m. Nov. 18, 2014
- TheStreet.com
Stock Movers: Why 4 Big Drug Stocks Are Rising Today
1:38 p.m. Nov. 18, 2014
- Investors Business Daily
Gilead Sciences (GILD) Stock Rises After European Commission Market Authorization for Harvoni
10:48 a.m. Nov. 18, 2014
- TheStreet.com
Buy Gilead Sciences Now At A Historic Low Valuation
8:52 a.m. Nov. 18, 2014
- Seeking Alpha
Dispelling Some Of The Myths Surrounding Gilead Sciences.
8:22 a.m. Nov. 18, 2014
- Seeking Alpha
Trade of the Day: Gilead Sciences (GILD)
3:16 a.m. Nov. 18, 2014
- InvestorPlace.com
Trade of the Day: Gilead Sciences Stock on Sale
7:56 p.m. Nov. 17, 2014
- InvestorPlace.com
Incyte Building Blockbuster Drug One Disease At A Time
2:58 p.m. Nov. 17, 2014
- Investors Business Daily
Earnings Forecast Report for Yahoo, Alibaba, Cliffs Natural Resources, Gilead Sciences, Apple, and Plug Power
8:45 a.m. Today8:45 a.m. Nov. 20, 2014
- PR Newswire - PRF
Knight Sells Priority Review Voucher to Gilead
5:11 p.m. Nov. 19, 2014
- Marketwired
European Commission Grants Marketing Authorization for Gilead’s
Harvoni®▼ (Ledipasvir/Sofosbuvir), the First
Single Tablet Regimen to Treat the Majority of Chronic Hepatitis C
Patients With Genotype 1 and 4
10:07 a.m. Nov. 18, 2014
- BusinessWire - BZX
Earnings Forecast Buzz for Baker Hughes, Halliburton, Apple, Gilead Sciences, Kinder Morgan, and Alibaba
8:45 a.m. Nov. 18, 2014
- PR Newswire - PRF
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene
9:10 a.m. Nov. 14, 2014
- PR Newswire - PRF
Reveal Earnings Forecast for BlackBerry, Twitter, Alibaba, Sirius XM, Gilead Sciences, and JD.Com
8:45 a.m. Nov. 14, 2014
- PR Newswire - PRF
Gilead Prices $4 Billion of Senior Unsecured Notes
5:59 p.m. Nov. 12, 2014
- BusinessWire - BZX
Earnings Forecast Recap for Alibaba, Apple, Zynga, Gilead Sciences, Dendreon, and Juniper
8:45 a.m. Nov. 12, 2014
- PR Newswire - PRF
Gilead Announces Phase 2 Data for Investigational All-Oral Regimen of
Sofosbuvir Plus GS-5816 for the Treatment of Chronic Hepatitis C
8:02 a.m. Nov. 11, 2014
- BusinessWire - BZX
Gilead Announces Harvoni Study Results in Chronic Hepatitis C
Patients with Advanced Liver Disease and Those Who Failed Prior Treatment
8:02 a.m. Nov. 11, 2014
- BusinessWire - BZX
Earnings Forecast Buzz for Alibaba, Genworth Financial, Gilead Sciences, Zynga, Abercrombie & Fitch, and Plug Power
8:45 a.m. Nov. 10, 2014
- PR Newswire - PRF
Medifocus to Be Broadcast on BNN and Fox Business News on November
8th and 9th, 2014
10:56 a.m. Nov. 7, 2014
- Marketwired
Linkage Biosciences Adds to Board Leadership
8:02 a.m. Nov. 7, 2014
- Marketwired
Critical Alerts For Delta Airlines, ConocoPhillips, Qualcomm, Kinder Morgan and Gilead Sciences Released By InvestorsObserver
9:31 a.m. Nov. 6, 2014
- PR Newswire - PRF
Gilead Submits New Drug Application to U.S. Food and Drug
Administration for Tenofovir Alafenamide (TAF)-Based Single Tablet
Regimen for HIV
8:32 a.m. Nov. 6, 2014
- BusinessWire - BZX
Earnings Forecast Buzz for Alibaba, GT Advanced Technologies, GoPro, Plug Power, Gilead Sciences, and American Realty Capital Properties
8:45 a.m. Nov. 4, 2014
- PR Newswire - PRF
Life-Science New Build Report: 200 New North American Sites in
Planning Represent Potential $15 Billion Investment, an Industrial
Info News Alert
6:16 a.m. Nov. 4, 2014
- Marketwired
Gilead Sciences Once Again Tops the List of California's Most Honored
Companies in Institutional Investor's All-America Executive Team
Ranking
6:15 a.m. Nov. 4, 2014
- Marketwired
Earnings Forecast Buzz for American Realty Capital Properties, Alibaba, Petroleo Brasileiro Petrobras SA, Gilead Sciences, RF Micro Devices, and GoPro
8:45 a.m. Oct. 30, 2014
- PR Newswire - PRF
Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly
8:35 a.m. Oct. 29, 2014
- PR Newswire - PRF
Gilead Sciences shares slide 1.7%
9:35 a.m. Nov. 19, 2014
- Sue Chang
Are consumers getting gouged on health care?
12:58 p.m. Nov. 18, 2014
- Russ Britt
The double-edged sword of growth-stock speculation
2:29 p.m. Nov. 14, 2014
- The Trading Deck
10 S&P 500 companies with the fastest revenue growth
8:28 a.m. Nov. 11, 2014
- Philip van Doorn
Merck, Dendreon miss out on health-care rally
12:39 p.m. Nov. 10, 2014
- Russ Britt
Gilead Sciences rises 2% to top S&P 500 gainers
9:31 a.m. Nov. 10, 2014
- Sue Chang
Visa shares rise after hours on earnings beat
6:50 p.m. Oct. 29, 2014
- Sue Chang
Warren Buffett best wear his trunks as Fed preps to end (pause) the printing
8:34 a.m. Oct. 29, 2014
- Shawn Langlois
Facebook, Gilead shares fall after hours
6:14 p.m. Oct. 28, 2014
- Sue Chang
Updates, advisories and surprises
5:01 p.m. Oct. 28, 2014
- MarketWatch
Sales of Gilead's pricey hepatitis C drug slow
4:26 p.m. Oct. 28, 2014
- MarketWatch.com
Gilead Sciences' stock pulls back from record high close after earnings miss
4:14 p.m. Oct. 28, 2014
- Tomi Kilgore
Gilead's stock drops 3.6% in after-hours trade after Q3 results
4:09 p.m. Oct. 28, 2014
- Tomi Kilgore
Gilead revises 2014 product sales outlook to $22 bln-$23 bln from $21 bln-$23 bln
4:08 p.m. Oct. 28, 2014
- Tomi Kilgore
Gilead Q3 Sovaldi sales $2.8 bln vs. $3.48 bln in Q2
4:07 p.m. Oct. 28, 2014
- Tomi Kilgore
Gilead Q3 sales top FactSet consensus estimate of $5.99 bln
4:07 p.m. Oct. 28, 2014
- Tomi Kilgore
Gilead Q3 sales $6.04 bln vs. $2.78 bln a year ago
4:07 p.m. Oct. 28, 2014
- Tomi Kilgore
Gilead Q3 net EPS $1.67 vs. 47 cents a year ago
4:06 p.m. Oct. 28, 2014
- Tomi Kilgore
Gilead Sciences Q3 adj. EPS $1.84 vs. FactSet consensus $1.92
4:06 p.m. Oct. 28, 2014
- Tomi Kilgore
Two biotech leaders to watch
2:12 p.m. Oct. 28, 2014
- The Trading Deck
France gets larger discount on Sovaldi than its neighbors
45 min ago12:04 p.m. Nov. 20, 2014
- Seeking Alpha
Global drug tab will breach trillion dollar mark this year
7:41 a.m. Today7:41 a.m. Nov. 20, 2014
- Seeking Alpha
CNBC's Stock Pops & Drops From November 19
6:38 a.m. Today6:38 a.m. Nov. 20, 2014
- benzinga.com
Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog
5:57 p.m. Nov. 19, 2014
- Zacks.com
Why We're Huge Fans Of Gilead
4:33 p.m. Nov. 19, 2014
- Seeking Alpha
Gilead buys FDA voucher for $125M
3:59 p.m. Nov. 19, 2014
- Seeking Alpha
Gilead: Pipeline Now Includes Potential Renal Blockbuster
11:35 a.m. Nov. 19, 2014
- Seeking Alpha
Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog
11:23 a.m. Nov. 19, 2014
- Zacks.com
Update: Gilead's Harvoni Receives Marketing Authorization In Europe
11:17 a.m. Nov. 19, 2014
- Seeking Alpha
Stock Market News for November 19, 2014 - Market News
10:10 a.m. Nov. 19, 2014
- Zacks.com
Stock Market Today: Oil Slump Fuels S&P 500 to Fresh Record High
4:09 p.m. Nov. 18, 2014
- TheStreet.com
Gilead's Value Without Its Hep C Franchise
4:07 p.m. Nov. 18, 2014
- Seeking Alpha
Stock Market Today: S&P 500 Notches New High as Oil Prices Slip and Slide
2:23 p.m. Nov. 18, 2014
- TheStreet.com
Stock Movers: Why 4 Big Drug Stocks Are Rising Today
1:38 p.m. Nov. 18, 2014
- Investors Business Daily
Gilead Sciences (GILD) Stock Rises After European Commission Market Authorization for Harvoni
10:48 a.m. Nov. 18, 2014
- TheStreet.com
Buy Gilead Sciences Now At A Historic Low Valuation
8:52 a.m. Nov. 18, 2014
- Seeking Alpha
Dispelling Some Of The Myths Surrounding Gilead Sciences.
8:22 a.m. Nov. 18, 2014
- Seeking Alpha
Trade of the Day: Gilead Sciences (GILD)
3:16 a.m. Nov. 18, 2014
- InvestorPlace.com
Trade of the Day: Gilead Sciences Stock on Sale
7:56 p.m. Nov. 17, 2014
- InvestorPlace.com
Incyte Building Blockbuster Drug One Disease At A Time
2:58 p.m. Nov. 17, 2014
- Investors Business Daily
Earnings Forecast Report for Yahoo, Alibaba, Cliffs Natural Resources, Gilead Sciences, Apple, and Plug Power
8:45 a.m. Today8:45 a.m. Nov. 20, 2014
- PR Newswire - PRF
Knight Sells Priority Review Voucher to Gilead
5:11 p.m. Nov. 19, 2014
- Marketwired
European Commission Grants Marketing Authorization for Gilead’s
Harvoni®▼ (Ledipasvir/Sofosbuvir), the First
Single Tablet Regimen to Treat the Majority of Chronic Hepatitis C
Patients With Genotype 1 and 4
10:07 a.m. Nov. 18, 2014
- BusinessWire - BZX
Earnings Forecast Buzz for Baker Hughes, Halliburton, Apple, Gilead Sciences, Kinder Morgan, and Alibaba
8:45 a.m. Nov. 18, 2014
- PR Newswire - PRF
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene
9:10 a.m. Nov. 14, 2014
- PR Newswire - PRF
Reveal Earnings Forecast for BlackBerry, Twitter, Alibaba, Sirius XM, Gilead Sciences, and JD.Com
8:45 a.m. Nov. 14, 2014
- PR Newswire - PRF
Gilead Prices $4 Billion of Senior Unsecured Notes
5:59 p.m. Nov. 12, 2014
- BusinessWire - BZX
Earnings Forecast Recap for Alibaba, Apple, Zynga, Gilead Sciences, Dendreon, and Juniper
8:45 a.m. Nov. 12, 2014
- PR Newswire - PRF
Gilead Announces Phase 2 Data for Investigational All-Oral Regimen of
Sofosbuvir Plus GS-5816 for the Treatment of Chronic Hepatitis C
8:02 a.m. Nov. 11, 2014
- BusinessWire - BZX
Gilead Announces Harvoni Study Results in Chronic Hepatitis C
Patients with Advanced Liver Disease and Those Who Failed Prior Treatment
8:02 a.m. Nov. 11, 2014
- BusinessWire - BZX
Earnings Forecast Buzz for Alibaba, Genworth Financial, Gilead Sciences, Zynga, Abercrombie & Fitch, and Plug Power
8:45 a.m. Nov. 10, 2014
- PR Newswire - PRF
Medifocus to Be Broadcast on BNN and Fox Business News on November
8th and 9th, 2014
10:56 a.m. Nov. 7, 2014
- Marketwired
Linkage Biosciences Adds to Board Leadership
8:02 a.m. Nov. 7, 2014
- Marketwired
Critical Alerts For Delta Airlines, ConocoPhillips, Qualcomm, Kinder Morgan and Gilead Sciences Released By InvestorsObserver
9:31 a.m. Nov. 6, 2014
- PR Newswire - PRF
Gilead Submits New Drug Application to U.S. Food and Drug
Administration for Tenofovir Alafenamide (TAF)-Based Single Tablet
Regimen for HIV
8:32 a.m. Nov. 6, 2014
- BusinessWire - BZX
Earnings Forecast Buzz for Alibaba, GT Advanced Technologies, GoPro, Plug Power, Gilead Sciences, and American Realty Capital Properties
8:45 a.m. Nov. 4, 2014
- PR Newswire - PRF
Life-Science New Build Report: 200 New North American Sites in
Planning Represent Potential $15 Billion Investment, an Industrial
Info News Alert
6:16 a.m. Nov. 4, 2014
- Marketwired
Gilead Sciences Once Again Tops the List of California's Most Honored
Companies in Institutional Investor's All-America Executive Team
Ranking
6:15 a.m. Nov. 4, 2014
- Marketwired
Earnings Forecast Buzz for American Realty Capital Properties, Alibaba, Petroleo Brasileiro Petrobras SA, Gilead Sciences, RF Micro Devices, and GoPro
8:45 a.m. Oct. 30, 2014
- PR Newswire - PRF
Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly
8:35 a.m. Oct. 29, 2014
- PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼